@plainyogurt21.bsky.social
MD Student, Investor, Builder writing adus.substack.com. Website www.subradata.com, Still on Twitter @plainyogurt21
@kyla.bsky.social
wrote a book called "in this economy?" | chair of the federal reserve | writing and youtube @ http://kyla.substack.com
@ianbremmer.com
president of @eurasiagroup.net and @gzeromedia.com political scientist, author. if you're not following some people you dislike, you're doing it wrong. i'm happy to help.
@downtownjoshbrown.bsky.social
Investor, CEO, Dad https://www.downtownjoshbrown.com/
@daichishimbo.bsky.social
Clinician-Scientist | Cardiologist | Professor | Expert in Cardiovascular Prevention and Hypertension | #Hypertension | Behavioral Medicine || Views are my own
@peterkolchinsky.bsky.social
Biotech investor. Virologist. Author: The Great American Drug Deal. Founder: No Patient Left Behind. Healthcare reform advocate. Daughter says I’m cool 75% of the time; son says 100%.
@antonioregalado.bsky.social
Journalist covering biotechnology for MIT Technology Review. Scoops about new methods in genetics and cell biology. The "playing God" beat. Gene editing, gene therapy, ancient DNA, synthetic embryos, cloning, etc.
@scottgottliebmd.bsky.social
Senior Fellow at the American Enterprise Institute. Partner, New Enterprise Associates. Contributor CNBC. 23rd Commissioner of the U.S. FDA. Public boards: Pfizer, Illumina, TempusAI.
@jonathanrockoff.bsky.social
Editor at @wsj.com. Board member of the Association of Health Care Journalists.
@investrclouseau.bsky.social
Not a CFA, biotech investor, still recovering from a decade in neuroscience, so now focusing on drugs that work
@carlquintanilla.bsky.social
25+ years at @CNBC and @NBCNews / @WSJ alum / board member, NY City Center
@jacobplieth.bsky.social
Journalist @ ApexOnco. The Wolverine Of Biotech / Mr ASH. Once had a blue tick. Interested in: oncology. Not interested in: what stock you bought today.
@benthefidler.bsky.social
Biotech journalist; Senior Editor, BioPharma Dive. Former Deputy Biotech Editor, Xconomy. #BioSky
@drorpoleg.com
I research technology’s impact on work, cities, and markets. Bylines: NY Times, The Atlantic, etc. DrorPoleg.com
@craigweekends.bsky.social
daniel craig reminds you that the weekend is here, every friday evening
@tommybeernba.bsky.social
Dad. Author/Founder of the "Knicks Centric" Substack. @TommyBeer on the other thing. I hope this thing is better
@pagerj2.bsky.social
Loving father to 2 smart and beautiful young women, husband to a wonderful wife, life sciences I-banker, and recovering late-stage cancer patient
@pdrworld.bsky.social
Biotech exec, pro drug developer. Amateur everything else: COOKING, ferments, preserving, charcuterie, fishing, gardening, weightlifting, BIRDER, photography, physics, literature, writer, history, DAD
@lisamjarvis.bsky.social
Chicago-based health & science columnist for Bloomberg Opinion @opinion.bsky.social. Writing about public health, medicine, emerging technologies (Crispr!), biotech & pharma. opinions=mine, She/her. Signal: lisajarvis.77
@adamfeuerstein.bsky.social
Reporter at STAT. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. Said one analyst: The likes of Adam Feuerstein attack viciously.
@applehelix.bsky.social
Entrepreneur. Drug hunter. Novice biotech scripophile. Anti-ideologues. Proudly blocked by Vinay Prasad. http://linkedin.com/in/jliang1/
@helenbranswell.bsky.social
I cover infectious diseases for STAT (www.statnews.com). 2020 Polk winner. Nieman '11. She/her. I write about H5N1 (in all species), Covid, polio, flu, Ebola, RSV, mpox, STIs. Find me on Signal: HBranswell.01
@pearlf.bsky.social
From Boston, MA. I'm @pearlf on the other blue-colored place. Founder of Cambridge BioPartners, Inc. I post mostly healthcare-related and biotech-related news items.
@maverickny.bsky.social
Scientist, cancer geek, journalist, Londoner, always curious, adventurer, explorer, immigrant, lover of curry, fine wine & football
@franksdavid.bsky.social
Biotech R&D strategy @ Pharmagellan. Prof of Practice of Biotech @ Tufts Biology. Bio, books, blog & more at www.pharmagellan.com. #biosky
@maxgelman.bsky.social
Reporting on pharma and biotech for Endpoints News. Baseball fan, Northwestern alum.
@matthewherper.bsky.social
I write about medicine at STAT. This is biology's century. Every data point has a face.
@dbsable.bsky.social
Doctor/teacher/writer. Ob/gyn and IVF doc. Roadie for Priya Mayadas. Adjunct @Columbia https://dbsable.substack.com
@biotechtv.bsky.social
News, stories, and educational videos about the biotechnology sector. Bringing biotech to life. 📺
@maxbayer.bsky.social
Pharma reporter at Endpoints News | Past: Fierce Biotech and CBS News | mbayer@endpointsnews.com or chat me for Signal. he/him
@gilman.bsky.social
Scientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player and mixologist, #immigrant, #BioSky. CEO, Arrakis Therapeutics and a variety of other things. https://www.michaelgilman.net/disclosures/
@dereklowe.bsky.social
Medicinal chemist / chemical biologist, author of “In the Pipeline” at http://science.org/blogs/pipeline. derekb.lowe@gmail.com and on Signal at Dblowe.18 All opinions are mine; I don’t speak for my employer in any way.
@kleinman.bsky.social
I like to post and see posts. Director of Research at The States Project, the views expressed here are my own.